EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of aplastic anemia with anti-lymphocyte globulin versus cyclosporin monotherapy



Treatment of aplastic anemia with anti-lymphocyte globulin versus cyclosporin monotherapy



Blood 94(10 SUPPL 1 PART 2): 12b, Nov 15




(PDF 0-2 workdays service: $29.90)

Accession: 035980985

Download citation: RISBibTeXText



Related references

Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93(7): 2191-2195, 1999

A comparison of Jurkat cell-reactive anti-T lymphocyte globulin and fetal anti-thymocyte globulin preparations in the treatment of aplastic anemia. Medical Principles and Practice 20(4): 341-344, 2011

Treatment of severe aplastic anemia by immunosuppressor anti-lymphocyte globulin/anti-thymus globulin as the chief medicine in combination with Chinese drugs. Chinese Journal of Integrative Medicine 15(2): 145-148, 2009

Controlled study of cyclosporin a cya versus antithymocyte globulin atg for treatment of severe aplastic anemia. Bone Marrow Transplantation 3(SUPPL 1): 241, 1988

A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia. Journal of Autoimmunity 5 Suppl A: 271-275, 1992

Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice. International Journal of Clinical and Experimental Medicine 8(9): 16334-9, 2015

Treatment of aplastic anemia with anti lymphocyte globulin. British Journal of Haematology 55(1): 7-16, 1983

Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia. Experimental Hematology 42(6): 431-438, 2014

Immunosuppressive treatment of aplastic anemia: a prospective, randomized multicenter trial evaluating antilymphocyte globulin (ALG) versus ALG and cyclosporin A. Blut 56(4): 191-192, 1988

Treatment of severe aplastic anemia with anti lymphocyte globulin. Pathologie-Biologie 26(1): 37-37, 1978

Treatment of aplastic anemia by anti lymphocyte globulin with or without marrow infusion. Clinics in Haematology 7(3): 611-621, 1978

Comparison of porcine anti-human lymphocyte globulin and rabbit anti-human thymocyte globulin in the treatment of severe aplastic anemia: a retrospective single-center study. European Journal of Haematology 96(3): 260-268, 2015

Complete remission in a case of aplastic anemia after treatment with anti lymphocyte globulin. Haematologica 64(1): 66-76, 1979

Treatment of severe aplastic anemia with anti lymphocyte globulin or bone marrow transplantation. British Medical Journal 282(6267): 860-863, 1981

Successful treatment of a case of hepatitis-associated severe aplastic anemia by anti-lymphocyte globulin (ALG). Japanese Journal of Clinical Hematology 31(11): 1836-1839, 1990